×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 

产品中心Cell Resources

联系我们CONTACT US

  • HCC1937 (人乳腺癌细胞) (STR鉴定正确)
  • HCC1937 (人乳腺癌细胞) (STR鉴定正确)
  • HCC1937 (人乳腺癌细胞) (STR鉴定正确)
  • HCC1937 (人乳腺癌细胞) (STR鉴定正确)
  • HCC1937 (人乳腺癌细胞) (STR鉴定正确)
  • HCC1937 (人乳腺癌细胞) (STR鉴定正确)
  • HCC1937 (人乳腺癌细胞) (STR鉴定正确)

HCC1937 (人乳腺癌细胞) (STR鉴定正确)

货号:CL-0093

规格:1×10⁶cells/T25培养瓶

价格: ¥1600

生长培养基:RPMI-164010% FBS1% P/S

数量: - +

  • HCC1937 (人乳腺癌细胞) (STR鉴定正确)
  • HCC1937 (人乳腺癌细胞) (STR鉴定正确)
  • HCC1937 (人乳腺癌细胞) (STR鉴定正确)
  • HCC1937 (人乳腺癌细胞) (STR鉴定正确)
  • HCC1937 (人乳腺癌细胞) (STR鉴定正确)
  • HCC1937 (人乳腺癌细胞) (STR鉴定正确)
  • HCC1937 (人乳腺癌细胞) (STR鉴定正确)

推荐搭配

套餐1:

HCC1937 (人乳腺癌细胞) (STR鉴定正确) ¥1600
HCC1937细胞专用培养基
  • ¥350
  • ¥450

现单独购买该产品也可享受限时优惠价!

细胞培养最优解!

套餐组合价:¥1950¥2050

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 HCC1937 (人乳腺癌细胞) (STR鉴定正确)
别称 HCC-1937
种属
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:2-1:4
推荐换液频率 2-3次/周
参考资料(来源文献)
背景描述 HCC1937细胞1995年10月13日最初来源于原发性导管癌,用了11.5个月建株。肿瘤分类为TNMⅡB期,3级。BRCA1分析表明,HCC1937细胞是BRCA 15382C突变纯合的,而来源于同一病人的类淋巴母细胞细胞株在这个突变位点上是杂合的。另两个家庭成员也有这个突变;一个同卵双生姐妹也患有乳腺癌。HCC1937细胞有一个后天的Tp53突变,而其野生型等位基因丢失;一个PTEN基因的后天的纯合缺失,以及多个与乳腺癌发病机理相关的位点上发生的杂合突变。HCC1937细胞Her2-neu和p53表达都呈阴性。HCC1937细胞的上皮细胞特异性标志上皮细胞糖蛋2(EGP2)和细胞角蛋白19都呈阳性;雌激素受体(ER)和孕酮(PR)表达阴性。
年龄(性别) 女性;23岁
组织来源 乳房;原发性导管癌;3级,ⅡB期
细胞类型 肿瘤细胞
肿瘤类型 乳腺癌细胞
生物安全等级 BSL-1
倍增时间 ~50-60 hours
受体表达情况 estrogen receptor, negative;progesterone receptor, negative
基因表达情况 Epithelial glycoprotein 2 (EGP2); cytokeratin 19
保藏机构 ATCC; CRL-2336 DSMZ; ACC-513
STR鉴定
  • STR位点信息
    Amelogenin X
    CSF1PO 12
    D2S1338 25
    D3S1358 18
    D5S818 12
    D7S820 9,10
    D8S1179 12,13
    D13S317 13
    D16S539 13,14
    D18S51 12
    D19S433 14,15
    D21S11 28
    FGA 20,22
    PentaD 9
    PentaE 13
    TH01 6
    TPOX 11
    vWA 16,17
    D6S1043 11
    D12S391 17.3,21
    D2S441 10
  • STR鉴定图
参考文献
文献列表
  • Inhibition of ATM promotes PD-L1 expression by activating JNK/c-Jun/TNF-α signaling axis in triple-negative breast cancer (2024-01-24)

    作者:Chenying Liu:1.Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China. ; Xiaolong Qian:1.Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China. ; Chunyan Yu:1.Tianjin Institute of Immunology, Department of Immunology, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Diseases and Microenvironment of Ministry of Education of China, Tianjin Medical University, Tianjin, 300070, China. ; Xiaoqing Xia:1.Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University

    期刊:Inhibition of ATM promotes PD-L1 expression by activating JNK/c-Jun/TNF-α signaling axis in triple-negative breast cancer

    DOI:10.1016/j.canlet.2024.216642

    影响因子 :9.7

    引用产品: MDA-MB-231 细胞 ,  HCC1937 细胞

  • Vertical pathway inhibition of receptor tyrosine kinases and BAD with synergistic efficacy in triple negative breast cancer (2024-01-10)

    作者:Yan Qin Tan:1.Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, 518055, People's Republic of China. ; 2.Tsinghua Berkeley Shenzhen Institute, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, 518055, Guangdong, People's Republic of China. ; Yi-Shiou Chiou:1.Tsinghua Berkeley Shenzhen Institute, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, 518055, Guangdong, People's Republic of China. ; 2.Master Degree Program in Toxicology, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, 807, Taiwan. ; 3.Shenzhen Bay Laboratory, Shenzhen, 518055, Guangdong, People's Republic of China. ; 4.Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, 807, Taiwan. ; Hui Guo:1.Tsinghua Berkeley Shenzhen Institute, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, 518055, Guangdong, People's R

    期刊:Vertical pathway inhibition of receptor tyrosine kinases and BAD with synergistic efficacy in triple negative breast cancer

    DOI:10.1038/s41698-023-00489-3

    影响因子 :7.9

    引用产品: MDA-MB-231/GFP 细胞 ,  BT-549 细胞 ,  HCC1937 细胞 ,  Hs 578T 细胞

  • Triple-Negative Breast Cancer Intrinsic FTSJ1 Favors Tumor Progression and Attenuates CD8+ T Cell Infiltration (2024-01-31)

    作者:Yangqing Sun:1.Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, China. ; Qingqing Liu:1.Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, China. ; Shangwei Zhong:1.The Cancer Research Institute and the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, China. ; Rui Wei:1.Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, China. ; Jun-Li Luo:1.Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, China. ; 2.The Cancer Research Institute and the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, China. ; 3.National Health Commission Key Laboratory of Birth Defect Research and Prevention, Hunan Provincial Maternal and Child Health Care Hospital, Changsha 410008, China. ;

    期刊:Triple-Negative Breast Cancer Intrinsic FTSJ1 Favors Tumor Progression and Attenuates CD8+ T Cell Infiltration

    DOI:10.3390/cancers16030597

    影响因子 :5.2

    引用产品: MDA-MB-231 细胞 ,  HCC1937 细胞 ,  4T1 细胞 ,  特级胎牛血清 ,  DMEM高糖 培养基 ,  RPMI-1640 培养基

  • The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation (2024-01-22)

    作者:Weijun Wu:1.Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China; Department of Oncology Radiotherapy, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China. ; Wenjing Wu:1.Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China; Department of Breast Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. ; Yingshi Zhou:1.Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, G

    期刊:The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation

    DOI:10.1016/j.jbc.2024.105671

    影响因子 :4.8

    引用产品: MCF 10A 细胞 ,  HCC1806 细胞 ,  HCC1937 细胞 ,  MDA-MB-468 细胞 ,  BT-20 细胞 ,  Hs 578T 细胞 ,  MDA-MB-436 细胞 ,  MCF 10A细胞专用培养基 ,  HCC1806细胞专用培养基 ,  HCC1937细胞专用培养基 ,  MDA-MB-468细胞专用培养基 (L15) ,  BT-20细胞专用培养基 ,  Hs 578T细胞专用培养基 ,  MDA-MB-436细胞专用培养基 (L15)

  • Discovery of Novel 4-Hydroxyquinazoline Derivatives: In Silico, In Vivo and In Vitro Studies Using Primary PARPi-Resistant Cell Lines (2024-03-21)

    作者:Lijie Zhu:1.School of Pharmacy, Shandong Second Medical University, Weifang 261053, China. ; Binzhuo Liu:1.School of Pharmacy, Shandong Second Medical University, Weifang 261053, China. ; Feng Jin:1.School of Pharmacy, Shandong Second Medical University, Weifang 261053, China. ; Weilong Cao:1.School of Pharmacy, Shandong Second Medical University, Weifang 261053, China. ; Guangzhao Xu:1.School of Pharmacy, Shandong Second Medical University, Weifang 261053, China. ; Xinwei Zhang:1.School of Pharmacy, Shandong Second Medical University, Weifang 261053, China. ; Peng Peng:1.School of Pharmacy (Preparatory), East China Normal University, Shanghai 200241, China. ; Dingding Gao:1.The Research Center of Chiral Drugs, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. ; Bin Wang:1.School of Pharmacy, Shandong Second Medical University, Weifang 261053, China. ; Kairui Feng:1.School of Pharmacy, Sh

    期刊:Discovery of Novel 4-Hydroxyquinazoline Derivatives: In Silico, In Vivo and In Vitro Studies Using Primary PARPi-Resistant Cell Lines

    DOI:10.3390/molecules29061407

    影响因子 :4.6

    引用产品: HCT-15 细胞 ,  HCC1937 细胞 ,  MDA-MB-231 细胞 ,  HL-7702 [L-02; LO2] 细胞 ,  NCM460 细胞

  • Oxypalmatine regulates proliferation and apoptosis of breast cancer cells by inhibiting PI3K/AKT signaling and its efficacy against breast cancer organoids (2023-03-10)

    作者:Xian Lin:1.Peking University Shenzhen Hospital; Shenzhen Key Laboratory of Inflammatory and Immunology Diseases, Shenzhen 518036, Guangdong, China. ; Dong Chen:1.Department of Thyroid and Breast Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong, China. ; Xinyu Chu:1.Department of Thyroid and Breast Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong, China. ; Lianxiang Luo:1.The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang 524023, Guangdong, China. ; Zhihao Liu:1.The First Clinical College, Guangdong Medical University, Zhanjiang 524023, Guangdong, China. ; Jian Chen:1.Peking University Shenzhen Hospital; Shenzhen Key Laboratory of Inflammatory and Immunology Diseases, Shenzhen 518036, Guangdong, China. Electronic address: chenjian@pkuszh.com. ;

    期刊:Oxypalmatine regulates proliferation and apoptosis of breast cancer cells by inhibiting PI3K/AKT signaling and its efficacy against breast cancer organoids

    DOI:10.1016/j.phymed.2023.154752

    影响因子 :7.9

    引用产品: MCF7 [MCF-7] 细胞 ,  HCC1937 细胞 ,  DU4475 细胞 ,  MDA-MB-231 细胞

  • Metabolome Sequencing Reveals that Protein Arginine-N-Methyltransferase 1 Promotes the Progression of Invasive Micropapillary Carcinoma of the Breast and Predicts a Poor Prognosis (2023-06-09)

    作者:Kailiang Wu:1.Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China; Department of Clinical Laboratory, Tianjin Medical University General Hospital, Tianjin, China. ; Weidong Li:1.Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China. ; Hanjiao Liu:1.Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.

    期刊:Metabolome Sequencing Reveals that Protein Arginine-N-Methyltransferase 1 Promotes the Progression of Invasive Micropapillary Carcinoma of the Breast and Predicts a Poor Prognosis

    DOI:10.1016/j.ajpath.2023.05.010

    影响因子 :6.0

    引用产品: HCC1937 细胞 ,  MDA-MB-231 细胞 ,  293T [HEK-293T] 细胞

  • Combined Inhibition of UBE2C and PLK1 Reduce Cell Proliferation and Arrest Cell Cycle by Affecting ACLY in Pan-Cancer (2023-10-27)

    作者:Keying Liang:1.School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China. ; Qian Wang:1.School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China. ; Li Qiu:1.School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China. ; Xiaocheng Gong:1.School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China. ; Zixi Chen:1.School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China. ; Haibo Zhang:1.School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China. ; Ke Ding:1.School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China. ; Yunfei Liu:1.School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China. ; Ji

    期刊:Combined Inhibition of UBE2C and PLK1 Reduce Cell Proliferation and Arrest Cell Cycle by Affecting ACLY in Pan-Cancer

    DOI:10.3390/ijms242115658

    影响因子 :5.6

    引用产品: HCC1937 细胞 ,  NCI-H520 细胞 ,  SNU-387 细胞 ,  SNU-182 细胞 ,  BEAS-2B 细胞 ,  MCF 10A细胞专用培养基

  • Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma (2023-08-04)

    作者:Yinghui Ye:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Yulou Luo:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China. ; Tong Guo:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Chenguang Zhang:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China. ; Yutian Sun:1.Department of Medical Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. ; Anping Xu:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Ling Ji:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Jianghua Ou:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China. ; Shang Ying Wu:1.Depa

    期刊:Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma

    DOI:10.3389/fendo.2023.1179050

    影响因子 :5.2

    引用产品: MCF7 [MCF-7] 细胞 ,  BT-20 细胞 ,  MDA-MB-231 细胞 ,  HCC1806 细胞 ,  HCC1937 细胞 ,  MCF7 [MCF-7]细胞专用培养基 ,  BT-20细胞专用培养基 ,  MDA-MB-231细胞专用培养基 (L15) ,  HCC1806细胞专用培养基 ,  HCC1937细胞专用培养基

  • Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells (2023-12-08)

    作者:Ming Lei:1.Department of Breast and Thyroid Surgery, The Second Affiliated Hospital, Hainan Medical University, Haikou, 570311, China. ; 2.Key Laboratory of Tropical Translational Medicine of Ministry of Education & School of Tropical Medicine, Hainan Medical University, Haikou, 571199, China. ; Yun-Long Zhang:1.Key Laboratory of Tropical Translational Medicine of Ministry of Education & School of Tropical Medicine, Hainan Medical University, Haikou, 571199, China. ; Feng-Ying Huang:1.Key Laboratory of Tropical Translational Medicine of Ministry of Education & School of Tropical Medicine, Hainan Medical University, Haikou, 571199, China. ; Heng-Yu Chen:1.Department of Breast and Thyroid Surgery, The Second Affiliated Hospital, Hainan Medical University, Haikou, 570311, China. ; Ming-Hui Chen:1.Key Laboratory of Tropical Translational Medicine of Ministry of Education & School of Tropical Medicine, Hainan Medical University, Haikou, 571199, China. ; Ri-Hong Wu:1.Key Laboratory of T

    期刊:Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells

    DOI:10.1038/s41598-023-49136-8

    影响因子 :4.6

    引用产品: MDA-MB-231 细胞 ,  HCC1937 细胞 ,  MDA-MB-468 细胞 ,  BT-20 细胞 ,  Hs 578T 细胞 ,  MCF 10A 细胞

  • Isopimaric acid, an ion channel regulator, regulates calcium and oxidative phosphorylation pathways to inhibit breast cancer proliferation and metastasis (2023-02-06)

    作者:Jiacheng Li:1.College of Life Science, Sichuan Normal University, Chengdu, Sichuan 610101, China; Zhejiang Provincial Key Laboratory of Cancer Prevention and Treatment Technology of Integrated Traditional Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, 310012, China. ; Xiaozhen Liu:1.Department of Medical and Radiation Oncology, Linyi People's Hospital, Linyi 276000, China. ; Lin Chen:1.Sericultural Research Institute, Zhejiang, Academy of Agricultural Sciences, Hangzhou 310021, China. ; Xinping Zhu:1.Zhejiang Provincial Key Laboratory of Cancer Prevention and Treatment Technology of Integrated Traditional Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, 310012, China. ; Zhihong Yu:1.Zhejiang Provincial Key Laboratory of Cancer Prevention and Treatment Technology of Integrated Traditional Chinese and Weste

    期刊:Isopimaric acid, an ion channel regulator, regulates calcium and oxidative phosphorylation pathways to inhibit breast cancer proliferation and metastasis

    DOI:10.1016/j.taap.2023.116415

    影响因子 :3.8

    引用产品: MDA-MB-231 细胞 ,  MCF7 [MCF-7] 细胞 ,  MDA-MB-468 细胞 ,  HCC1937 细胞 ,  MDA-MB-453 细胞 ,  4T1 细胞 ,  MCF 10A 细胞 ,  Annexin V-FITC/ PI荧光双染细胞凋亡检测试剂盒

  • Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity (2023-07-08)

    作者:Yuting Zhang:1.Department of Breast Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, 510000, China. ; Yinghui Ye:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, 518000, China. ; Anping Xu:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, 518000, China. ; Yulou Luo:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, 830000, China. ; Yutian Sun:1.Department of Medical Oncology, School of Medicine, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, 610000, China. ; Wei Zhang:1.Department of Breast Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, 510000, China. zhangwei@jnu.edu.cn. ; Ling Ji:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, 518000, China. 1120303921@qq.com. ;

    期刊:Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity

    DOI:10.1007/s00432-023-05028-y

    影响因子 :3.6

    引用产品: MCF7 [MCF-7] 细胞 ,  MCF7 [MCF-7]细胞专用培养基 ,  BT-20 细胞 ,  BT-20细胞专用培养基 ,  MDA-MB-231 细胞 ,  MDA-MB-231细胞专用培养基 (L15) ,  MDA-kb2 细胞 ,  MDA-kb2细胞专用培养基 (L15) ,  HCC1937 细胞 ,  HCC1937细胞专用培养基

  • Scoparone inhibits breast cancer cell viability through the NF‑κB signaling pathway (2023-05-17)

    作者:Xiaoying Wu:1.Mongolian Medical College, Inner Mongolia University for Nationalities, Tongliao, Inner Mongolia Autonomous Region 028000, P.R. China. ; Xiaobo Li:1.Department of Hematology, Mongolian Medical Hospital, Fuxin Mongolian Autonomous County 123199, P.R. China. ; Jing Li:1.Department of Hematology, Mongolian Medical Hospital, Fuxin Mongolian Autonomous County 123199, P.R. China. ; Xinrui Zhao:1.Liaoning Boaotaihe Health Technology Co., Ltd., Fuxin, Liaoning 123000, P.R. China. ; Yongyuan Cui:1.Liaoning Boaotaihe Health Technology Co., Ltd., Fuxin, Liaoning 123000, P.R. China. ; Chaolu Eerdun:1.Medical Department, Inner Mongolia University for Nationalities, Tongliao, Inner Mongolia Autonomous Region 028000, P.R. China. ;

    期刊:Scoparone inhibits breast cancer cell viability through the NF‑κB signaling pathway

    DOI:10.3892/etm.2023.12027

    影响因子 :2.7

    引用产品: MCF 10A 细胞 ,  MCF7 [MCF-7] 细胞 ,  MDA-MB-231 细胞 ,  ZR-75-1 细胞 ,  HCC1937 细胞 ,  293 [HEK-293] 细胞

  • RAMP2-AS1 inhibits CXCL11 expression to suppress malignant phenotype of breast cancer by recruiting DNMT1 and DNMT3B (2004-02-20)

    作者:Li Li:1.Department of Breast Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, PR China. Electronic address: 156333039@qq.com. ; Ya-Ping Gan:1.Department of Gynaecology and Obstetrics, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong Province, PR China. ; Hui Peng:1.Nanchang University, Nanchang 330006, Jiangxi Province, PR China. ;

    期刊:RAMP2-AS1 inhibits CXCL11 expression to suppress malignant phenotype of breast cancer by recruiting DNMT1 and DNMT3B

    DOI:10.1016/j.yexcr.2022.113139

    影响因子 :3.7

    引用产品: HCC1937 细胞 ,  MDA-MB-231 细胞 ,  MDA-MB-453 细胞 ,  MCF7 [MCF-7] 细胞 ,  MCF 10A 细胞

  • LncRNA OTUD6B-AS1 promotes paclitaxel resistance in triple negative breast cancer by regulation of miR-26a-5p/MTDH pathway-mediated autophagy and genomic instability (2011-01-20)

    作者:Peng-Ping Li:1.Department of Breast-Thyroid Surgery, Department of General Surgery, The First Hospital of Xiaoshan District, Hangzhou, Zhejiang Province 311000, China. ; Rong-Guo Li:1.Department of Breast-Thyroid Surgery, Department of General Surgery, The First Hospital of Xiaoshan District, Hangzhou, Zhejiang Province 311000, China. ; Yu-Qing Huang:1.Department of Breast-Thyroid Surgery, Department of General Surgery, The First Hospital of Xiaoshan District, Hangzhou, Zhejiang Province 311000, China. ; Jin-Pian Lu:1.The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province 310000, China. ; Wei-Jun Zhang:1.Department of Breast-Thyroid Surgery, Department of General Surgery, The First Hospital of Xiaoshan District, Hangzhou, Zhejiang Province 311000, China. ; Zhen-Yu Wang:1.Department of Breast-Thyroid Surgery, Department of General Surgery, The First Hospital of Xiaoshan District, Hangzhou, Zhejiang Province 311000, China. ;

    期刊:LncRNA OTUD6B-AS1 promotes paclitaxel resistance in triple negative breast cancer by regulation of miR-26a-5p/MTDH pathway-mediated autophagy and genomic instability

    DOI:10.18632/aging.203672

    影响因子 :5.2

    引用产品: MDA-MB-231 细胞 ,  HCC1937 细胞

  • Combination of the 6-thioguanine and disulfiram/Cu synergistically inhibits proliferation of triple-negative breast cancer cells by enhancing DNA damage and disrupting DNA damage checkpoint (2011-01-20)

    作者:Meiran Chu:1.Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital, Jilin University, Changchun 130021, China; College of Veterinary Medicine, Jilin University, Changchun, Jilin 130062, China. ; Xinglan An:1.Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital, Jilin University, Changchun 130021, China. ; Daoyu Zhang:1.Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital, Jilin University, Changchun 130021, China. ; Qi Li:1.Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital, Jilin University, Changchun 130021, China. ; Xiangpeng Dai:1.Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital, Jilin University, Changchun 130021, China. ; Hao Yu:1.College of Animal Science, Jilin University, Changchun, Jilin 130062, China. ; Ziyi Li:1.Key Laboratory of Organ Regene

    期刊:Combination of the 6-thioguanine and disulfiram/Cu synergistically inhibits proliferation of triple-negative breast cancer cells by enhancing DNA damage and disrupting DNA damage checkpoint

    DOI:10.1016/j.bbamcr.2021.119169

    影响因子 :5.1

    引用产品: HCC1937 细胞

  • Thioguanine Induces Apoptosis in Triple-Negative Breast Cancer by Regulating PI3K–AKT Pathway (2010-00-20)

    作者:Daoyu Zhang:1.Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital, Jilin University, Changchun, China. ; Xinglan An:1.Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital, Jilin University, Changchun, China. ; Qi Li:1.Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital, Jilin University, Changchun, China. ; Xiaxia Man:1.Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital, Jilin University, Changchun, China. ; Meiran Chu:1.Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital, Jilin University, Changchun, China. ; Hao Li:1.Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital, Jilin University, Changchun, China. ; Nan Zhang:1.Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First H

    期刊:Thioguanine Induces Apoptosis in Triple-Negative Breast Cancer by Regulating PI3K–AKT Pathway

    DOI:10.3389/fonc.2020.524922

    影响因子 :4.7

    引用产品: HCC1937 细胞

  • 点击展开收起列表
FAQs

Q:{{item.question}}

A:

暂无数据
产品资料
注:百度浏览器无法支持扫一扫功能,请输入识别码,获取相应产品资料

识别码示意图

确定
邱国娜/胡文君

邱国娜/胡文君

【 上海 】

何帆

何帆

【 陕西、甘肃、宁夏、青海、新疆 】

 熊经理

熊经理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

刘本佳

刘本佳

【江苏(除南京外)】

章臣雄

章臣雄

【 广州 】

杜焱炜

杜焱炜

【 四川、云南、西藏 】

田博浩

田博浩

【 重庆、贵州 】

石文平

石文平

【 北京、辽宁 】

胡文君

胡文君

【江西】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 山东 】

尹国文

尹国文

【浙江】

唐小花

唐小花

【 吉林、黑龙江 】

付帅

付帅

【 安徽 】

朱俊宇

朱俊宇

【 河南、广西 】

李庆祖

李庆祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文强

梅文强

【福建】

林钊光

林钊光

【南京】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询

关注微信公众号